VRCHOVECKÁ, Kateřina, Monika PÁVKOVÁ GOLDBERGOVÁ, H. ENGQVIST and M. PUJARI-PALMER. Cytocompatibility and Bioactive Ion Release Profiles of Phosphoserine Bone Adhesive: Bridge from In Vitro to In Vivo. Biomedicines. Basel: MDPI, 2022, vol. 10, No 4, p. 1-29. ISSN 2227-9059. Available from: https://dx.doi.org/10.3390/biomedicines10040736.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cytocompatibility and Bioactive Ion Release Profiles of Phosphoserine Bone Adhesive: Bridge from In Vitro to In Vivo
Authors VRCHOVECKÁ, Kateřina (203 Czech Republic, belonging to the institution), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution), H. ENGQVIST (guarantor) and M. PUJARI-PALMER.
Edition Biomedicines, Basel, MDPI, 2022, 2227-9059.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.700
RIV identification code RIV/00216224:14110/22:00125642
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/biomedicines10040736
UT WoS 000785046500001
Keywords in English phosphoserine; bone tissue adhesive; calcium phosphate cement; odontoblast; osteoblast; cytotoxicity; ion release; in vitro
Tags 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 20/2/2023 11:11.
Abstract
One major challenge when developing new biomaterials is translating in vitro testing to in vivo models. We have recently shown that a single formulation of a bone tissue adhesive, phosphoserine modified cement (PMC), is safe and resorbable in vivo. Herein, we screened many new adhesive formulations, for cytocompatibility and bioactive ion release, with three cell lines: MDPC23 odontoblasts, MC3T3 preosteoblasts, and L929 fibroblasts. Most formulations were cytocompatible by indirect contact testing (ISO 10993-12). Formulations with larger amounts of phosphoserine (>50%) had delayed setting times, greater ion release, and cytotoxicity in vitro. The trends in ion release from the adhesive that were cured for 24 h (standard for in vitro) were similar to release from the adhesives cured only for 5–10 min (standard for in vivo), suggesting that we may be able to predict the material behavior in vivo, using in vitro methods. Adhesives containing calcium phosphate and silicate were both cytocompatible for seven days in direct contact with cell monolayers, and ion release increased the alkaline phosphatase (ALP) activity in odontoblasts, but not pre-osteoblasts. This is the first study evaluating how PMC formulation affects osteogenic cell differentiation (ALP), cytocompatibility, and ion release, using in situ curing conditions similar to conditions in vivo.
Links
MUNI/A/1391/2021, interní kód MUName: Molekulární, buněčná, tkáňová a systémová patofyziologie vybraných komplexních nemocí (Acronym: KOMPLEX_PF)
Investor: Masaryk University
NU20-08-00149, research and development projectName: Multicentrické hodnocení hypersenzitivní reakce u pacientů indikovaných k totální náhradě kloubu včetně hodnocení důvodů reimplanace
Investor: Ministry of Health of the CR, Subprogram 1 - standard
PrintDisplayed: 22/7/2024 02:32